« FDA to seek public comment on IOM recommendations The FDA | Main | Winn-Dixie Issues Voluntary Recall On Winn-Dixie Choco Charm Chocolate Drink »

FDA approves blood-thinning drug Brilinta to treat acute coronary syndromes


FDA approves blood-thinning drug Brilinta to treat acute coronary syndromes
The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).
 

©2006 FDA-News.com. All rights reserved.